(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Artemis II astronauts say they're "ready to go" for moon launch - 2Golan resident convicted of spying for Iran after passing tank movement, missile-impact data
- 3Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
- 4From Educational Loans to Obligation Free: Independence from the rat race Accomplished
- 5Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
- Israeli military says it hit dozens of military facilities in Tehran
- Most loved Seared Chicken: Which Chain Rules?
- Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful!
- 2025 among world's three hottest years on record, WMO says
- Surging measles cases are 'fire alarm' warning that other diseases could be next
- Students were skipping my astrophysics class to play video games – so I turned the class itself into a video game
- How to watch the last supermoon of the year
- A new mom skipped a routine appointment. An infected cut led to a devastating diagnosis
- 6 Shades Brands For Seniors
